Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.

MLA

Koerich, Suélyn, et al. “Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.” Current Neuropharmacology, vol. 21, no. 2, 2023, pp. 219–34. EBSCOhost, https://doi.org/10.2174/1570159X20666220922153903.

APA

Koerich, S., Parreira, G. M., de Almeida, D. L., Vieira, R. P., & de Oliveira, A. C. P. (2023). Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions. Current Neuropharmacology, 21(2), 219–234. https://doi.org/10.2174/1570159X20666220922153903

Chicago

Koerich, Suélyn, Gabriela Machado Parreira, Douglas Lamounier de Almeida, Rafael Pinto Vieira, and Antônio Carlos Pinheiro de Oliveira. 2023. “Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.” Current Neuropharmacology 21 (2): 219–34. doi:10.2174/1570159X20666220922153903.